Nuclear expression of human apurinic/apyrimidinic endonuclease (HAP1/Ref-1) in head-and-neck cancer is associated with resistance to chemoradiotherapy and poor outcome

Michael I Koukourakis,Alexandra Giatromanolaki,Stelios Kakolyris,Sivridis E,Vassilis Georgoulias,George Funtzilas,Ian D Hickson,Kevin C Gatter,Adrian L Harris
DOI: https://doi.org/10.1016/S0360-3016(00)01561-3
IF: 8.013
2001-01-01
International Journal of Radiation Oncology*Biology*Physics
Abstract:Purpose: HAP1/Ref-1 endonuclease is involved in the repair of DNA strand breaks and in the activation of DNA binding of several transcription factors. HAP1 is also a potent activator of wild type p53. It therefore has multiple possible roles in the response of human cancer to radiotherapy and chemotherapy.
What problem does this paper attempt to address?